# AMBRISENTAN
> **ANDA210058** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2019-03-28
## Drug
- **FDA Application Number:** ANDA210058
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMBRISENTAN
- **Generic name:** AMBRISENTAN
- **Active ingredients:** AMBRISENTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Zydus Lifesciences Limited
- **First approval:** 2019-03-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210058)
---
*AI Analytics · CC0 1.0*